key: cord-0854034-22kwkjhf authors: Norsa, Lorenzo; Pietro, Bonaffini; Indriolo, Amedeo; Valle, Clarissa; Aurelio, Sonzogni; Sironi, Sandro title: Poor outcome of intestinal ischemic manifestations of COVID 19 date: 2020-06-20 journal: Gastroenterology DOI: 10.1053/j.gastro.2020.06.041 sha: be8713a89d8643aab0163ff4c4a88d374959752b doc_id: 854034 cord_uid: 22kwkjhf nan Since the end of February, Bergamo's province in Northern Italy has become the second epicenter worldwide after Wuhan of SARS CoV-2 infection. Papa Giovanni XXIII hospital was elected as tertiary referral center for COVID-19 with 500 dedicated beds and more than 1500 hospitalization so far. In this first two months experience, a mounting evidence has been collected that coagulopathy is one of the possible predictors of poor outcomes in COVID-19 patients 1 . Although the most affected organ is the lung -in terms of both pneumonia 1 We found that seven patients fulfilled clinical and radiological criteria for intestinal ischemia, and are described in Table 1 . All patients presented with gastrointestinal (GI) symptoms. Six were evaluated with abdominal contrast-enhanced CT scan. Two demonstrated evidence of ischemic colitis with marked wall edema and layered enhancement, involving either the whole large bowel or the right colon. Four had evidence of ischemia (thin wall with reduced enhancement or signs of pneumatosis intestinalis), involving either the small bowel and/or the right-transverse colon (supplementary figure 1 ). Among the latter four, thromboembolic filling defects in inferior vena cava and superior mesenteric vein were found in one. Two of the six patients showed also unexplained splenic infarcts. One additional patient was diagnosed of ischemic colitis through endoscopy (supplementary figure 2) . D-dimer was tested in six patients and resulted markedly elevated in all of them. Six out of seven also underwent a thoracic CT scan which showed pulmonary thromboembolism in 1 case. Four out of seven patients (50%) died either in the first 48 hours after admission (3) or after surgery (1) In the study period pre-COVID we identified 3 patients which fulfilled enrolment criteria of intestinal ischemia. This account for an increase of 133% of intestinal ischemia admitted to our hospital during COVID 19 pandemic. One patient died from the sequelae of small bowel resection due to ischemia. The remnant two recovered from ischemic colitis. All three patients showed important comorbities: chronic renal insufficiency on dialysis for the first who died, Hodgkin lymphoma in the second and type 2 diabetes and hypertension in the third. Mortality among patients with COVID 19 related intestinal ischemia was 1.7-fold higher (95% CI 0.3-9.6) than in the remnant cohort. This is -to our knowledge -the first series exploring clinical features and outcomes or COVID-19 patients presenting with intestinal ischemia. Our study confirms previous case report on association of intestinal ischemia with COVID 19 3 and demonstrates and increased mortality rate of patients with intestinal ischemia associated in the COVID 19 period if compared with SARS-CoV-2 negative patients. GI-symptoms have been described in 10% of patients with COVID-19 4 . In the majority of cases these symptoms are mild and self-limiting even if they seem to increase the risk of complications 4 . We show that GI symptoms at admission could also be the expression of an underlying intestinal ischemia. A state of hypercoagulability has been demonstrated in most of the COVID-19 patients admitted to ICU by the study of thromboelastography 5 . Quantitative D-dimer has already been proposed as the best single marker of hypercoagulability in COVID-19 patients as well as a negative prognostic marker 6 . Furthermore a recent publication has proposed downregulation of Angiotensin-Converting-Enzyme 2 (ACE2) as possible pathogenetic hypothesis for acute vascular damage 7 . The presence of ACE2 protein, which has been proved to be a cell receptor for SARS-CoV-2, has been demonstrated by immunofluorescence in the gastrointestinal epithelium 8 . The increase in mortality rate of this series account for part of the + 568% mortality of Bergamo province reported in the first trimester of 2020 when compared with the first trimester of the previous 4 years (2015-2019) (https://www.istat.it/it/files/2020/05/Rapporto_Istat_ISS.pdf). No final conclusions can be drawn on such a small number of patients due to the ongoing characteristic of the pandemic. However, our experience suggests that a high level of suspicion for intestinal ischemia should be maintained in COVID-19 patients presenting with GI symptoms or with arising abdominal pain, since this complication could account for an increase mortality risk. Nevertheless, in this subset a D-dimer elevation should not only trigger towards a prompt prophylactic use of anticoagulants, but also lead to consider an early abdominal CT scan in patients with suggestive complaints or biochemical markers of intestinal ischemia. Further analysis will help to define the role of SARS-CoV-2 in the pathogenesis of such a detrimental manifestation. Clinical Characteristics of Coronavirus Disease 2019 in China Abdominal Imaging Findings in COVID-19: Preliminary Observations Acute Mesenteric Ischemia in Severe Coronavirus-19 (COVID-19): Possible Mechanisms and Diagnostic Pathway Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction Evidence for Gastrointestinal Infection of SARS-CoV-2